Literature DB >> 31641070

Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons.

Michael A Metrick1,2, Natalia do Carmo Ferreira1, Eri Saijo1, Andrew G Hughson1, Allison Kraus1, Christina Orrú1, Michael W Miller3, Gianluigi Zanusso4, Bernardino Ghetti5, Michele Vendruscolo2, Byron Caughey6.   

Abstract

Recent work with prion diseases and synucleinopathies indicates that accurate diagnostic methods for protein-folding diseases can be based on the ultrasensitive, amplified measurement of pathological aggregates in biospecimens. A better understanding of the physicochemical factors that control the seeded polymerization of such aggregates, and their amplification in vitro, should allow improvements in existing assay platforms, as well as the development of new assays for other proteopathic aggregates. Here, we systematically investigated the effects of the ionic environment on the polymerization of tau, α-synuclein, and the prion protein (PrP) induced by aggregates in biospecimens. We screened salts of the Hofmeister series, a relative ordering of strongly and weakly hydrated salts that tend to precipitate or solubilize proteins. We found that sensitivities of tau-based assays for Alzheimer's seeds and PrP-based assays for prions were best in weakly hydrated anions. In contrast, we saw an inverse trend with different tau-based assays, improving detection sensitivity for progressive supranuclear palsy seeds by ≈106 Hofmeister analysis also improved detection of sporadic Creutzfeldt-Jakob disease prions in human nasal brushings and chronic wasting disease prions in deer-ear homogenates. Our results demonstrate strong and divergent influences of ionic environments on the amplification and detection of proteopathic seeds as biomarkers for protein-folding diseases.

Entities:  

Keywords:  Hofmeister series; RT-QuIC; ion hydration; protein misfolding; tau

Year:  2019        PMID: 31641070      PMCID: PMC6859373          DOI: 10.1073/pnas.1909322116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Role of protein-water interactions and electrostatics in alpha-synuclein fibril formation.

Authors:  Larissa A Munishkina; Jeremy Henriques; Vladimir N Uversky; Anthony L Fink
Journal:  Biochemistry       Date:  2004-03-23       Impact factor: 3.162

Review 2.  Interactions between macromolecules and ions: The Hofmeister series.

Authors:  Yanjie Zhang; Paul S Cremer
Journal:  Curr Opin Chem Biol       Date:  2006-10-10       Impact factor: 8.822

3.  4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration.

Authors:  Eri Saijo; Michael A Metrick; Shunsuke Koga; Piero Parchi; Irene Litvan; Salvatore Spina; Adam Boxer; Julio C Rojas; Douglas Galasko; Allison Kraus; Marcello Rossi; Kathy Newell; Gianluigi Zanusso; Lea T Grinberg; William W Seeley; Bernardino Ghetti; Dennis W Dickson; Byron Caughey
Journal:  Acta Neuropathol       Date:  2019-10-16       Impact factor: 17.088

4.  Prediction of aggregation-prone regions in structured proteins.

Authors:  Gian Gaetano Tartaglia; Amol P Pawar; Silvia Campioni; Christopher M Dobson; Fabrizio Chiti; Michele Vendruscolo
Journal:  J Mol Biol       Date:  2008-05-13       Impact factor: 5.469

Review 5.  Beyond the Hofmeister Series: Ion-Specific Effects on Proteins and Their Biological Functions.

Authors:  Halil I Okur; Jana Hladílková; Kelvin B Rembert; Younhee Cho; Jan Heyda; Joachim Dzubiella; Paul S Cremer; Pavel Jungwirth
Journal:  J Phys Chem B       Date:  2017-02-08       Impact factor: 2.991

6.  Cell-free formation of protease-resistant prion protein.

Authors:  D A Kocisko; J H Come; S A Priola; B Chesebro; G J Raymond; P T Lansbury; B Caughey
Journal:  Nature       Date:  1994-08-11       Impact factor: 49.962

7.  Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.

Authors:  Kenneth W Drombosky; Sascha Rode; Ravi Kodali; Tija C Jacob; Michael J Palladino; Ronald Wetzel
Journal:  Neurobiol Dis       Date:  2018-08-30       Impact factor: 5.996

8.  Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays.

Authors:  Jason M Wilham; Christina D Orrú; Richard A Bessen; Ryuichiro Atarashi; Kazunori Sano; Brent Race; Kimberly D Meade-White; Lara M Taubner; Andrew Timmes; Byron Caughey
Journal:  PLoS Pathog       Date:  2010-12-02       Impact factor: 6.823

9.  Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease.

Authors:  Christina D Orrú; Jue Yuan; Brian S Appleby; Baiya Li; Yu Li; Dane Winner; Zerui Wang; Yi-An Zhan; Mark Rodgers; Jason Rarick; Robert E Wyza; Tripti Joshi; Gong-Xian Wang; Mark L Cohen; Shulin Zhang; Bradley R Groveman; Robert B Petersen; James W Ironside; Miguel E Quiñones-Mateu; Jiri G Safar; Qingzhong Kong; Byron Caughey; Wen-Quan Zou
Journal:  Sci Transl Med       Date:  2017-11-22       Impact factor: 17.956

10.  Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease.

Authors:  Allison Kraus; Eri Saijo; Michael A Metrick; Kathy Newell; Christina J Sigurdson; Gianluigi Zanusso; Bernardino Ghetti; Byron Caughey
Journal:  Acta Neuropathol       Date:  2018-12-20       Impact factor: 17.088

View more
  24 in total

1.  Breakthroughs in antemortem diagnosis of neurodegenerative diseases.

Authors:  Glenn C Telling
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-30       Impact factor: 11.205

Review 2.  Application of yeast to studying amyloid and prion diseases.

Authors:  Yury O Chernoff; Anastasia V Grizel; Aleksandr A Rubel; Andrew A Zelinsky; Pavithra Chandramowlishwaran; Tatiana A Chernova
Journal:  Adv Genet       Date:  2020-05-04       Impact factor: 1.944

3.  Computational maturation of a single-domain antibody against Aβ42 aggregation.

Authors:  Jiacheng Lin; Chiara Figazzolo; Michael A Metrick; Pietro Sormanni; Michele Vendruscolo
Journal:  Chem Sci       Date:  2021-10-07       Impact factor: 9.825

4.  α-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders.

Authors:  Ivan Martinez-Valbuena; Emily Swinkin; Enrique Santamaria; Joaquin Fernandez-Irigoyen; Valerie Sackmann; Ain Kim; Jun Li; Paulina Gonzalez-Latapi; Greg Kuhlman; Suvorit Subhas Bhowmick; Naomi P Visanji; Anthony E Lang; Gabor G Kovacs
Journal:  Acta Neuropathol       Date:  2022-06-24       Impact factor: 15.887

5.  Bank vole prion protein extends the use of RT-QuIC assays to detect prions in a range of inherited prion diseases.

Authors:  Tze How Mok; Akin Nihat; Connie Luk; Danielle Sequeira; Mark Batchelor; Simon Mead; John Collinge; Graham S Jackson
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

Review 6.  Proteopathic Seed Amplification Assays for Neurodegenerative Disorders.

Authors:  Natália do Carmo Ferreira; Byron Caughey
Journal:  Clin Lab Med       Date:  2020-06-16       Impact factor: 2.172

7.  Examination of SOD1 aggregation modulators and their effect on SOD1 enzymatic activity as a proxy for potential toxicity.

Authors:  Ravinder Malik; Christian Corrales; Miriam Linsenmeier; Huda Alalami; Niki Sepanj; Gal Bitan
Journal:  FASEB J       Date:  2020-07-23       Impact factor: 5.834

8.  Opposite Regulatory Effects of Immobilized Cations on the Folding Vs. Assembly of Melittin.

Authors:  Lanlan Yu; Zhun Deng; Wenbo Zhang; Shuli Liu; Feiyi Zhang; Jianjian Zhou; Chunhua Ma; Chenxuan Wang
Journal:  Front Chem       Date:  2021-06-11       Impact factor: 5.221

9.  Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt-Jakob disease.

Authors:  Bradley R Groveman; Natalia C Ferreira; Simote T Foliaki; Ryan O Walters; Clayton W Winkler; Brent Race; Andrew G Hughson; Gianluigi Zanusso; Cathryn L Haigh
Journal:  Sci Rep       Date:  2021-03-09       Impact factor: 4.996

10.  Failure To Detect Prion Infectivity in Ticks following Prion-Infected Blood Meal.

Authors:  Ronald A Shikiya; Anthony E Kincaid; Jason C Bartz; Travis J Bourret
Journal:  mSphere       Date:  2020-09-02       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.